UA98140C2 - КРИСТАЛЛИЧЕСКИЙ 1-(ЦИКЛОГЕКСИЛОКСИКАРБОНИЛОКСИ)ЭТИЛ-1-((2'-ЦИАНОБИФЕНИЛ-4-ИЛ)МЕТИЛ)-2-ЭТОКСИ-1H-БЕНЗО[d]ИМИДАЗОЛ-7-КАРБОКСИЛАТ И СПОСОБ ЕГО ПОЛУЧЕНИЯ - Google Patents
КРИСТАЛЛИЧЕСКИЙ 1-(ЦИКЛОГЕКСИЛОКСИКАРБОНИЛОКСИ)ЭТИЛ-1-((2'-ЦИАНОБИФЕНИЛ-4-ИЛ)МЕТИЛ)-2-ЭТОКСИ-1H-БЕНЗО[d]ИМИДАЗОЛ-7-КАРБОКСИЛАТ И СПОСОБ ЕГО ПОЛУЧЕНИЯInfo
- Publication number
- UA98140C2 UA98140C2 UAA200910746A UAA200910746A UA98140C2 UA 98140 C2 UA98140 C2 UA 98140C2 UA A200910746 A UAA200910746 A UA A200910746A UA A200910746 A UAA200910746 A UA A200910746A UA 98140 C2 UA98140 C2 UA 98140C2
- Authority
- UA
- Ukraine
- Prior art keywords
- cyclohexyloxycarbonyloxy
- cyanobiphenyl
- benzo
- imidazole
- carboxylate
- Prior art date
Links
- SIQUUIKHTASBBJ-UHFFFAOYSA-N 1-cyclohexyloxycarbonyloxyethyl 3-[[4-(2-cyanophenyl)phenyl]methyl]-2-ethoxybenzimidazole-4-carboxylate Chemical compound C=12N(CC=3C=CC(=CC=3)C=3C(=CC=CC=3)C#N)C(OCC)=NC2=CC=CC=1C(=O)OC(C)OC(=O)OC1CCCCC1 SIQUUIKHTASBBJ-UHFFFAOYSA-N 0.000 title 1
- GHOSNRCGJFBJIB-UHFFFAOYSA-N Candesartan cilexetil Chemical compound C=12N(CC=3C=CC(=CC=3)C=3C(=CC=CC=3)C3=NNN=N3)C(OCC)=NC2=CC=CC=1C(=O)OC(C)OC(=O)OC1CCCCC1 GHOSNRCGJFBJIB-UHFFFAOYSA-N 0.000 abstract 3
- 229960004349 candesartan cilexetil Drugs 0.000 abstract 3
- -1 1-(cyclohexyloxycarbonyloxy)ethyl Chemical group 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Данное изобретение касается 1-(циклогексилоксикарбонилокси)этил-1-((2'-цианобифенил-4-ил)метил)-2- этокси-1Н-бензо[d]имидазол-7-карбоксилата в кристаллической форме и способа его получения, который является промежуточной стадией в получении кандесартана цилексэтила.Данное изобретение также касается получения кандесартана цилексэтила и фармацевтической композиции, которая содержит кандесартана цилексэтил.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SI200700100A SI22488A (sl) | 2007-04-24 | 2007-04-24 | Kristalni 1-(cikloheksiloksikarboniloksi)etil 1-((2'-cianobifenil-4-il)metil) - 2-etoksi-1h-benz(d)imidazol -7-karboksilat in proces za njegovo pripravo |
| PCT/EP2008/054997 WO2008129077A2 (en) | 2007-04-24 | 2008-04-24 | Crystalline 1-(cyclohexyloxycarbonyloxy) ethyl 1-((2'-cyanobiphenyl-4-yl)methyl)-2-ethoxy-1h-benzo[d]imidazole-7-carboxylate and a process for its preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA98140C2 true UA98140C2 (ru) | 2012-04-25 |
Family
ID=39671465
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200910746A UA98140C2 (ru) | 2007-04-24 | 2008-04-24 | КРИСТАЛЛИЧЕСКИЙ 1-(ЦИКЛОГЕКСИЛОКСИКАРБОНИЛОКСИ)ЭТИЛ-1-((2'-ЦИАНОБИФЕНИЛ-4-ИЛ)МЕТИЛ)-2-ЭТОКСИ-1H-БЕНЗО[d]ИМИДАЗОЛ-7-КАРБОКСИЛАТ И СПОСОБ ЕГО ПОЛУЧЕНИЯ |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP2139866B1 (ru) |
| CN (1) | CN101679300A (ru) |
| AT (1) | ATE495160T1 (ru) |
| DE (1) | DE602008004486D1 (ru) |
| EA (1) | EA200901295A1 (ru) |
| PL (1) | PL2139866T3 (ru) |
| SI (2) | SI22488A (ru) |
| UA (1) | UA98140C2 (ru) |
| WO (1) | WO2008129077A2 (ru) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103073537A (zh) * | 2013-02-01 | 2013-05-01 | 武汉工程大学 | 坎地沙坦酯的合成工艺 |
| CN103724277A (zh) * | 2014-01-20 | 2014-04-16 | 华润赛科药业有限责任公司 | 一种阿齐沙坦中间体的制备方法 |
| CN104788429B (zh) * | 2015-03-06 | 2018-07-06 | 浙江美诺华药物化学有限公司 | 一种通过脱除三苯甲基保护基制备沙坦类药物的方法 |
| CN107089972B (zh) * | 2017-06-23 | 2021-05-18 | 浙江华海药业股份有限公司 | 一种坎地沙坦酯的制备方法 |
| CN113456601A (zh) * | 2021-05-26 | 2021-10-01 | 江苏宇锐医药科技有限公司 | 一种坎地沙坦酯氢氯噻嗪复方片剂的制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5196444A (en) * | 1990-04-27 | 1993-03-23 | Takeda Chemical Industries, Ltd. | 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof |
| CN1204125C (zh) * | 2000-12-27 | 2005-06-01 | 中国科学院上海药物研究所 | 坎地沙坦酯的合成新路线 |
| CN1425654A (zh) * | 2003-01-07 | 2003-06-25 | 江苏省药物研究所 | 一种2-烷氧基苯并咪唑类化合物的制备方法 |
| TWI346108B (en) * | 2004-08-23 | 2011-08-01 | Bristol Myers Squibb Co | A method for preparing irbesartan and intermediates thereof |
| EP1764365A1 (en) * | 2005-09-20 | 2007-03-21 | KRKA, D.D., Novo Mesto | A process for the preparation of sartan derivates and intermediates useful in such process |
-
2007
- 2007-04-24 SI SI200700100A patent/SI22488A/sl not_active IP Right Cessation
-
2008
- 2008-04-24 SI SI200830176T patent/SI2139866T1/sl unknown
- 2008-04-24 AT AT08749704T patent/ATE495160T1/de not_active IP Right Cessation
- 2008-04-24 EA EA200901295A patent/EA200901295A1/ru unknown
- 2008-04-24 DE DE602008004486T patent/DE602008004486D1/de active Active
- 2008-04-24 PL PL08749704T patent/PL2139866T3/pl unknown
- 2008-04-24 WO PCT/EP2008/054997 patent/WO2008129077A2/en not_active Ceased
- 2008-04-24 CN CN200880012940A patent/CN101679300A/zh active Pending
- 2008-04-24 UA UAA200910746A patent/UA98140C2/ru unknown
- 2008-04-24 EP EP08749704A patent/EP2139866B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ATE495160T1 (de) | 2011-01-15 |
| WO2008129077A2 (en) | 2008-10-30 |
| EA200901295A1 (ru) | 2010-04-30 |
| SI2139866T1 (sl) | 2011-04-29 |
| DE602008004486D1 (de) | 2011-02-24 |
| WO2008129077A3 (en) | 2009-01-29 |
| SI22488A (sl) | 2008-10-31 |
| EP2139866B1 (en) | 2011-01-12 |
| EP2139866A2 (en) | 2010-01-06 |
| PL2139866T3 (pl) | 2011-04-29 |
| CN101679300A (zh) | 2010-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200745149A (en) | Crystalline form of 1'-(1-methylethyl)-4'-[(2-fluoro-4-methoxyphenyl)methyl]-5'-methyl-1H-pyrazol-3'-O-β-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments | |
| MX367154B (es) | Formas solidas de acido 3-(6-(1-(2,2-difluorobenzo[d] [1,3]dioxol-5-il)ciclopropancarboxamido)-3-metilpiridin-2-il)benz oico. | |
| MX2010005827A (es) | Derivados de aminopirazol. | |
| UA99787C2 (en) | Lactams as beta secretase inhibitors | |
| WO2012090043A8 (en) | Novel solid state forms of azilsartan medoxomil and preparation thereof | |
| MX2009010567A (es) | Derivados de imidazolidinona. | |
| WO2008006795A3 (en) | Indole compounds | |
| JO2682B1 (en) | Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof | |
| IL202654A0 (en) | Novel crystalline form of 3-(difluormethyl)-1-methyl-n-(3',4',5',-trifluor[1,1'-biphenyl]-2-yl)-1h-pyrazol-4-carboxamide | |
| WO2009021868A3 (en) | Novel piperazine amide derivatives | |
| UA98140C2 (ru) | КРИСТАЛЛИЧЕСКИЙ 1-(ЦИКЛОГЕКСИЛОКСИКАРБОНИЛОКСИ)ЭТИЛ-1-((2'-ЦИАНОБИФЕНИЛ-4-ИЛ)МЕТИЛ)-2-ЭТОКСИ-1H-БЕНЗО[d]ИМИДАЗОЛ-7-КАРБОКСИЛАТ И СПОСОБ ЕГО ПОЛУЧЕНИЯ | |
| WO2007128478A3 (en) | Pharmaceutical composition | |
| WO2010129636A3 (en) | Lenalidomide polymorph | |
| IL183104A0 (en) | Method for production of candesartan | |
| MX2010004505A (es) | Piperidinas 4,4-disustituidas. | |
| WO2009021943A3 (de) | Neues herstellverfahren | |
| WO2008059513A3 (en) | Compounds suitable as modulators of hdl | |
| NZ599218A (en) | Process for the manufacture of organic compounds | |
| MY179041A (en) | Crystalline forms of a 3-carboxypropyl-aminotetralin compound | |
| WO2009056617A3 (en) | 4,4-disubstituted piperdines as renin inhibitors | |
| MX2010006218A (es) | Compuestos organicos. | |
| WO2010122580A3 (en) | Piperidine derivatives as inhibitors of renin | |
| EP1984356A4 (en) | IMPROVED PROCESS FOR THE PREPARATION OF CANDESARTAN CILEXETIL | |
| WO2005123721A3 (en) | Amorphous and polymorphic forms of candesartan cilexetil | |
| NO20090125L (no) | Benzimidazolderivater som skal anvendes som antagonist for CB1-reseptor |